Auswahl der wissenschaftlichen Literatur zum Thema „Medulloblastoma paediatric“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Medulloblastoma paediatric" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Medulloblastoma paediatric"
Tan, Geok Chin. „Molecular Subtyping of Paediatric Medulloblastoma by Immunohistochemistry“. Medicine & Health 15, Nr. 2 (31.12.2020): 124–39. http://dx.doi.org/10.17576/mh.2020.1502.13.
Der volle Inhalt der QuelleAbbas, Zahra, Jessica Buck, Mathew Ancliffe, Clara Andradas Arias, Meegan Howlett, Hilary Hii, Terrance Johns, Siddhartha Mitra, Nicholas Gottardo und Raelene Endersby. „MODL-18. Enhancing anti-CD47 mAb efficacy with radiotherapy for Group 3 paediatric medulloblastoma in preclinical models“. Neuro-Oncology 24, Supplement_1 (01.06.2022): i172—i173. http://dx.doi.org/10.1093/neuonc/noac079.641.
Der volle Inhalt der QuelleLasseini, Ali, Aliyu Muhammad Koko und Ashafa Birnin Gwari Isa. „Demographic and Interventional Pattern of Pediatric Brain Tumors Managed at UDUTH Sokoto: A Decade Review“. International Journal of Research and Review 10, Nr. 10 (21.10.2023): 374–77. http://dx.doi.org/10.52403/ijrr.20231045.
Der volle Inhalt der QuelleTang, Phua Hwee, Sharon Low, Enrica Tan und Kenneth Chang. „IMG-01. DWI RATIO OF HISTOLOGICAL MOLECULAR SUBTYPES OF PAEDIATRIC MEDULLOBLASTOMAS“. Neuro-Oncology 22, Supplement_3 (01.12.2020): iii354. http://dx.doi.org/10.1093/neuonc/noaa222.337.
Der volle Inhalt der QuelleGrosshans, David R. „Proton therapy for paediatric medulloblastoma“. Lancet Oncology 17, Nr. 3 (März 2016): 258–59. http://dx.doi.org/10.1016/s1470-2045(15)00217-x.
Der volle Inhalt der QuelleBurki, Talha Khan. „Postoperative radiotherapy for paediatric medulloblastoma“. Lancet Oncology 17, Nr. 9 (September 2016): e381. http://dx.doi.org/10.1016/s1470-2045(16)30390-4.
Der volle Inhalt der QuellePadovani, L., G. Horan und T. Ajithkumar. „Radiotherapy Advances in Paediatric Medulloblastoma Treatment“. Clinical Oncology 31, Nr. 3 (März 2019): 171–81. http://dx.doi.org/10.1016/j.clon.2019.01.001.
Der volle Inhalt der QuelleMcLendon, Friedman, Fuchs, Kun und Bigner. „Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study“. Histopathology 34, Nr. 2 (Februar 1999): 154–62. http://dx.doi.org/10.1046/j.1365-2559.1999.00577.x.
Der volle Inhalt der QuelleWong, Gabriel Chun-Hei, Queenie Junqi Huang, Manix Fung Man Poon, Nellie Yuk-Fei Chung, Queenie Hoi-Wing Wong, Zhen-Yu Zhang, Zhi-Feng Shi et al. „PATH-32. CLINICAL AND MUTATIONAL PROFILES OF ADULT MEDULLOBLASTOMA GROUPS“. Neuro-Oncology 22, Supplement_2 (November 2020): ii171. http://dx.doi.org/10.1093/neuonc/noaa215.713.
Der volle Inhalt der QuelleAllen, Joseph, Susannah Entwistle, Beth Coyle und Alistair N. Hume. „MDB-46. ARE RAB40 SMALL GTPASES DRIVERS OF MEDULLOBLASTOMA PATHOGENESIS?“ Neuro-Oncology 26, Supplement_4 (18.06.2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.495.
Der volle Inhalt der QuelleDissertationen zum Thema "Medulloblastoma paediatric"
Nasir, Aishah. „An investigation of metastatic markers in models of paediatric medulloblastoma“. Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/42405/.
Der volle Inhalt der QuelleMather, Rebecca Louise. „Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma“. Thesis, University of Portsmouth, 2016. https://researchportal.port.ac.uk/portal/en/theses/deacetylation-of-gd3a-as-a-potential-therapeutic-strategy-for-paediatric-medulloblastoma(d5e04f18-7985-48ff-807a-0962e6037835).html.
Der volle Inhalt der QuelleNair, Omesan. „Profiling medulloblastoma and juvenile pilocytic astrocytoma brain tumours in a South African paediatric cohort“. Doctoral thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/26896.
Der volle Inhalt der QuelleGeorge, Courtney M. „Medulloblastoma: New animal models, preclinical drug testing, and characterising immune infiltrates“. Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2022. https://ro.ecu.edu.au/theses/2575.
Der volle Inhalt der QuelleOkiro, Patricia Opon. „Morphological classification of childhood medulloblastomas with β-catenin immunohistochemistry and mycn fluorescent in situ hybridization“. Master's thesis, University of Cape Town, 2015. http://hdl.handle.net/11427/15733.
Der volle Inhalt der QuellePenco-Campillo, Manon. „Le VEGFC et les récepteurs CXCR1/2 : des cibles pertinentes pour le traitement des médulloblastomes pédiatriques“. Electronic Thesis or Diss., Université Côte d'Azur, 2022. http://www.theses.fr/2022COAZ6025.
Der volle Inhalt der QuelleMedulloblastoma (MB) is the most common and aggressive pediatric brain tumor. Despite aggressive multimodal treatment, resulting in significant side effects, 30% of patients develop resistance and relapse following the appearance of metastases within 5 years. Recurrences cannot be controlled by conventional (radio- and chemotherapy) or targeted (anti-angiogenic, anti-inflammatory, anti-immune checkpoint) treatments. The objective of my thesis is therefore to discover new targets and relevant therapeutic strategies for these patients at diagnosis or after a relapse.MBs are highly vascularized tumors. The phenomenon of resistance is, in part, linked to the development of blood (angiogenesis) and lymphatic (lymphangiogenesis) vessels in the tumor, which constitute the main routes of metastatic dissemination. The lymphatic growth factor, VEGFC, and its receptors/co-receptors are the major players in lymphangiogenesis. In the first part of my thesis, I showed that VEGFC is inversely correlated to MB cell growth and aggressiveness. Indeed, VEGFC decreases the proliferation and migration of MB cells, as well as their ability to form pseudo-vessels in vitro, by an autocrine signalization. Cells resistant to radiotherapy show elevated levels of VEGFC and lose their ability to migrate and form pseudo-vessels. Irradiation reduces the aggressiveness of MB cells by a VEGFC-dependent process. VEGFC-overexpressing cells and radiation-resistant cells form smaller experimental tumors in nude mice. Thus, VEGC appears to be a negative regulator of MB growth. These results pave the way for the development of pro-VEGFC therapies in these cancers.In the second part of my thesis, I correlated the expression of the ELR+CXCL/CXCR1-2 pro-angiogenic and pro-inflammatory signaling pathway to shorter survival in patients with MB. I showed that a novel pharmacological inhibitor (C29) of CXCR1-2 receptors inhibits proliferation, CXCL8/CXCR1-2-dependent migration, invasion and pseudo-vessel formation by susceptible or resistant MB cells to radiotherapy. C29 reduces the growth of experimental MBs in an ex vivo organotypic mouse model and crosses the blood-brain barrier. Thus, targeting CXCR1-2 represents a promising strategy for the treatment of pediatric MB, at first line or at relapse.Key words: pediatric medulloblastoma, VEGFC/VEGFR, CXCR1-2, ELR+CXCL cytokines, targeted therapy, lymphangiogenesis, angiogenesis
Sorensen, James. „Therapeutic Efficacy of a Co-Q10 Analogue in Combating Cachexia and Mortality Induced by Gold-Standard Paediatric Chemotherapy Regimens“. Thesis, 2020. https://vuir.vu.edu.au/41826/.
Der volle Inhalt der QuelleBücher zum Thema "Medulloblastoma paediatric"
Taylor, Roger E., Barry L. Pizer, Nancy Tarbell, Alba A. Brandes und Stephen Lowis. Embryonal and pineal tumours. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0009.
Der volle Inhalt der QuelleBuchteile zum Thema "Medulloblastoma paediatric"
Janzen, Laura, und Ute Bartels. „Paediatric Neuro-Oncology: Medulloblastoma“. In Physician's Field Guide to Neuropsychology, 133–46. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8722-1_8.
Der volle Inhalt der QuelleBellapukonda, Snigdha, und Praneeth Suvvari. „Paediatric Case of Medulloblastoma for Whole Brain Radiotherapy“. In Problem Based Learning Discussions in Onco-Anesthesia and Onco-Critical Care, 203–12. Singapore: Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-6339-3_19.
Der volle Inhalt der QuelleShahi, Mehdi Hayat. „Mitogen-activated protein (MAP) kinase Roles in Paediatric Brain Tumor “Medulloblastoma”“. In Role of Signaling Pathways in Brain Tumorigenesis, 209–18. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-15-8473-2_18.
Der volle Inhalt der QuelleNelson, M., C. Diebler und W. St C. Forbes. „Paediatric medulloblastoma: atypical CT features at presentation in the SIOP II trial“. In Proceedings of the XIV Symposium Neuroradiologicum, 516–17. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-49329-4_191.
Der volle Inhalt der QuelleTalamonti, Cinzia, Stefano Piffer, Daniela Greto, Monica Mangoni, Antonio Ciccarone, Paolo Dicarolo, Maria Evelina Fantacci et al. „Radiomic and Dosiomic Profiling of Paediatric Medulloblastoma Tumours Treated with Intensity Modulated Radiation Therapy“. In Computer Analysis of Images and Patterns, 56–64. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-29930-9_6.
Der volle Inhalt der QuelleYoung, A. „Craniotomy for medulloblastoma“. In Paediatric Anaesthesia, 81–85. CRC Press, 2004. http://dx.doi.org/10.3109/9780203413012-15.
Der volle Inhalt der QuelleMassimino, Maura, Eric Bouffet und Vijay Ramaswamy. „Embryonal Tumours“. In Oxford Textbook of Cancer in Children, 188–97. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198797210.003.0023.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Medulloblastoma paediatric"
Lyman, Stephanie. „730 An exploration of existing and potential novel biomarkers in paediatric medulloblastoma“. In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Liverpool, 28–30 June 2022. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2022. http://dx.doi.org/10.1136/archdischild-2022-rcpch.495.
Der volle Inhalt der QuelleShoji Hayashi, Daniel, Ana Luiza Ongaro Seidinger Conte, Isadora Olenscki Gilli, Gabriel Lopes Centoducatte und José Andrés Yunes. „Identification of genetic profile associated with response to treatment with protein Smoothened (SMO) inhibitors in paediatric medulloblastoma patients“. In XXV Congresso de Iniciação Cientifica da Unicamp. Campinas - SP, Brazil: Galoa, 2017. http://dx.doi.org/10.19146/pibic-2017-78106.
Der volle Inhalt der Quelle